Alcohol Use Disorder
Conditions
Brief summary
The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.
Detailed description
The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and who are enrolled in Aware Recovery Care's In-Home Addiction Treatment program where Care Teams will monitor cloud-based breathalyzer results. Soberlink's cloud-based breathalyzer system will provide data to Care Team if the Client has relapsed or is not compliant with testing through the Soberlink System. Clients will use Soberlink for 180 days within context of routine alcohol use disorder treatment at Aware Recovery Care.
Interventions
DEVICESoberlink
Soberlink delivers real-time blood alcohol results to people who support individuals in recovery from alcohol use disorder. In-Home Addiction Treatment program Care Team monitors and responds to results as part of care to improve treatment outcomes.
Sponsors
Soberlink Healthcare LLC
In-Home Addiction Treatment Institute, Inc.
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
21 Years to 75 Years
Inclusion criteria
* Male or female subject between ages of 21-75 years old * Subject active in In-Home Addiction Treatment Program (Aware Recovery Care) * Subject admitted to program with American Society of Addiction Medicine (ASAM) Assessment score 1.5-2.5 * Primary or secondary diagnosis is alcohol use disorder * Subject is willing to use Soberlink Device to provide Blood Alcohol Content (BAC) * Subject is willing to discuss Soberlink test results with Care Team * Subject is willing to sign Soberlink Client Agreement * Subject is English speaking and reading
Exclusion criteria
* Alcohol use disorder is not a primary or secondary diagnosis * Subject is not between ages of 21 and 75 years old * Subject is currently taking anti-alcohol/craving medications (Antabuse, Campral, Vivitrol) * Subject will not be in the United States through duration of study * Subject is unwilling to properly use the device * Subject is non-English speaking and reading * Subject is a child, adolescent, cognitively impaired, diagnosed with a mental disorder involving depersonalization or active psychotic symptoms * Active withdrawal/alcohol use within 72 hours of start of participation * Subject is using Soberlink data for a child custody or legal consequence
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Client Survey Related to use of Soberlink | Completed at end of 180 days duration of subject participation | Measures self-report of quality of life and experience with device using 5-point Likert scale (minimum Strongly Disagree, maximum Strongly Agree) |
| Rate of Retention in Treatment | 180 days duration of subject participation | Participation in In-Home Addiction Treatment program using length of stay reports. |
| Brief Addiction Monitor questionnaire | Conducted monthly throughout 180 days duration of subject participation | Measure change in client report of symptoms related to alcohol use disorder |
| Positive Outcomes Measures Survey | Completed at week 3 or 4 and Week 20 during 180 days duration of subject participation | Measures changes in quality of life using client self-report inquiring about employment, connection to care team, community engagement using yes/no answer key |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Relapse Rates | Measured throughout 180 days duration of subject participation | Occurrence of alcohol use |
| Compliance with Testing | Measured throughout 180 days duration of subject participation | Occurrence of Missed Tests |
| Hospitalization | Measured throughout 180 days duration of subject participation | Occurrence of Emergency Room and Inpatient hospital admissions |
| Detox and Residential Admissions | Measured throughout 180 days duration of subject participation | Occurrence of residential treatment and detox admissions |
Countries
United States
Outcome results
None listed